MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0022466
Molclone Labs Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹25.57 Cr
▲ 12% YoY
Net profit · FY 2025
₹1.73 Cr
Net margin 6.8%
EBITDA · FY 2025
₹5.58 Cr
EBITDA margin 21.8%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹18.63 Cr
Satisfied ₹5.9 Cr
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Molclone Labs Private Limited
Data last updated:
Molclone Labs Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2013PTC094105. Its GSTIN is 33AAICM9580A1ZI (Tamil Nadu).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Meikavalputhur Ulaganathan Gomathy Thirumavalavan and Kayalvizhi Thirumavalavan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 73 Kasi Estate 2nd Street Jafferkhanpent, Chennai, Tamil Nadu, India – 600083.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.57 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.73 Cr (net margin 6.8%) and EBITDA of ₹5.58 Cr (EBITDA margin 21.8%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 27% over five years.
The company is associated with 1 brand: Molclone Labs. As per MCA filings, the company has open charges of ₹18.63 Cr and satisfied charges of ₹5.9 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹24 Lakh; the latest was in September 2014. Its 6 peer companies in the Healthcare industry (Formulations, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Ever Health Life Sciences Private Limited with revenue of ₹25.78 Cr.
Molclone Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0022466). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website molclonelabs.com.
Company details
CIN U24100TN2013PTC094105
Registration Number 094105
Incorporation Date 10 December 2013
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0022466
Key People
Meikavalputhur Ulaganathan Gomathy Thirumavalavan Director Kayalvizhi Thirumavalavan Director Recognitions & Rankings of Molclone Labs
Contact details
Molclone Labs Private Limited's registered office is in Chennai, Tamil Nadu. Its website is molclonelabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address73 Kasi Estate 2nd Street Jafferkhanpent, Chennai, Tamil Nadu, India – 600083
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Molclone Labs Private Limited, buy the company report.
Comprehensive company report
Molclone Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Molclone Labs operates one associated brand: Molclone Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical APIs and nutraceuticals for partners. | molclonelabs.com |
Business activity
The main business activity of Molclone Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Molclone Labs Private Limited, buy the company report.
Financials of Molclone Labs Private Limited
FY 2025 filings availableMolclone Labs Private Limited reported revenue of ₹25.57 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹25.57 Cr ▲ 12%
Net profit · FY 2025
₹1.73 Cr margin 6.8%
EBITDA · FY 2025
₹5.58 Cr margin 21.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 31%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 72%
3 years · compounded
▲ 51%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 12% growth in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.8% | ||||
| Net Profit Margin | 6.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Molclone Labs Private Limited, buy the company report.
Board of directors of Molclone Labs Private Limited
Molclone Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meikavalputhur Ulaganathan Gomathy Thirumavalavan | Director | 10 Dec 2013 | 12 Years 10 Months | Current |
| Kayalvizhi Thirumavalavan Also directs: Power Soft Drinks LLP, Shri Ayyanar Phytochem Private Limited | Director | 10 Dec 2013 | 12 Years 10 Months | Current |
Peer comparison
Molclone Labs Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Formulations, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ever Health Life Sciences Private Limited | ₹25.78 Cr (FY 2022) | -38.0% | Vijayawada, Andhra Pradesh, India | |||
| Pharmanova Specialties Private Limited | ₹25.7 Cr (FY 2023) | 13.0% | Mumbai, Maharashtra, India | |||
| Jineka Healthcare Private Limited | ₹25.65 Cr (FY 2025) | -3.0% | Haridwar, Uttarakhand, India | |||
| Link Pharmachem Limited | ₹25.62 Cr (FY 2025) | -16.0% | Vadodara, Gujarat, India | |||
| Molclone Labs Private Limitedthis company | ₹25.57 Cr (FY 2025) | ₹1.73 Cr | 6.8% | 12.0% | Chennai, Tamil Nadu, India | |
| Crestchem Limited | ₹25.52 Cr (FY 2025) | 19.0% | Indrad, Gujarat, India | |||
| D R Johns Lab Private Limited | ₹25.41 Cr (FY 2025) | 60.0% | New Delhi, Delhi, India |
To see the full peer comparison of Molclone Labs Private Limited, buy the company report.
Auditor
Molclone Labs Private Limited is audited by S.VISHNU AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.VISHNU AND CO | FY 2023 | 005179S |
Shareholding
The shareholding of Molclone Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Molclone Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.63 Cr
Satisfied charges
₹5.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2024 | 100972977 | Others | ₹3 Cr | Open | |
| 27 Feb 2024 | 100885738 | Others | ₹8.5 Cr | Open | |
| 27 Jul 2023 | 100753885 | Others | ₹7.13 Cr | Open | |
| 05 Mar 2021 | 100423205 | Others | ₹3.4 Cr | Satisfied | |
| 16 Jul 2014 | 10513853 | Bank of Maharashtra | ₹2.5 Cr | Satisfied |
To see the full charge records of Molclone Labs Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Molclone Labs Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹24 Lakh; the latest was in September 2014.
Total deals
1
Funding round
1
Disclosed funding
₹24 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2014 | Funding round | ₹24 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Molclone Labs Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by Swati Spentose Pvt Ltd | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Swati Spentose Pvt Ltd | Disposed |
To see the full case history of Molclone Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Molclone Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Molclone Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICM9580A1ZI | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Molclone Labs Private Limited, buy the company report.
Recent activity
Molclone Labs Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Thirumavalavan Vikneshkannan ceased to be Director on 10 Jan 2024.
AGM
Molclone Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Molclone Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others of Rs. 713.39 Lakh registered on 27 Jul 2023 with Charge ID 100753885 was modified on 12 Dec 2024.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 100972977 was registered on 04 Sep 2024.
Charges
A charge with Others amounted to Rs. 850.00 Lakh with Charge ID 100885738 was registered on 27 Feb 2024.
Ceased
Thirumavalavan Vikneshkannan ceased to be Director.
Charges
A charge with Others amounted to Rs. 713.39 Lakh with Charge ID 100753885 was registered on 27 Jul 2023.
Charges
A charge registered on 05 Mar 2021 via Charge ID 100423205 with Others was fully satisfied on 19 May 2023.
Charges
A charge with Others of Rs. 340.00 Lakh registered on 05 Mar 2021 with Charge ID 100423205 was modified on 09 Nov 2022.
Charges
A charge registered on 16 Jul 2014 via Charge ID 10513853 with Bank Of Maharashtra was fully satisfied on 21 Apr 2021.
Charges
A charge with Others amounted to Rs. 340.00 Lakh with Charge ID 100423205 was registered on 05 Mar 2021.
Charges
A charge with Bank Of Maharashtra amounted to Rs. 250.00 Lakh with Charge ID 10513853 was registered on 16 Jul 2014.
3 earlier events are in the company report.
Frequently asked questions
Molclone Labs is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 December 2013 (13+ years old) and is registered under CIN U24100TN2013PTC094105.
Molclone Labs has 2 current directors:
- Meikavalputhur Ulaganathan Gomathy Thirumavalavan - Director
- Kayalvizhi Thirumavalavan - Director
The latest financial statements of Molclone Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Molclone Labs is 33AAICM9580A1ZI, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Molclone Labs is U24100TN2013PTC094105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molclone Labs has 3 court cases on record: 3 filed against it. 1 is pending.
Molclone Labs was incorporated on 10 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.
Molclone Labs has 1 deal on record (1 funding round), with disclosed funding of ₹24 Lakh; the latest was in September 2014.
The peers of Molclone Labs by revenue are Ever Health Life Sciences Private Limited, Pharmanova Specialties Private Limited, Jineka Healthcare Private Limited, Link Pharmachem Limited, Crestchem Limited and 1 more, all in the Healthcare industry (Formulations, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Thirumavalavan Vikneshkannan ceased to be Director on 10 Jan 2024. Kayalvizhi Thirumavalavan was appointed as Director on 10 Dec 2013. Meikavalputhur Ulaganathan Gomathy Thirumavalavan was appointed as Director on 10 Dec 2013.
Yes, Molclone Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0022466).